clinical trials
Recent Rosacea Blog Posts
Promoted as being safer than systemic antibiotics, a 3% formulation of topical minocycline gel has passed Phase 2 clinical trials and is readying to commence Phase 3 trials. The owners of the product, currently named HY-01 – Hovione are promoting their in-development topical as more moisturising than other comparable topicals, and less likely to induce […]
A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability and promising efficacy in rosacea” and also showcases “the value of our anhydrous hydrophilic topical delivery system.” The trial will compare the […]
A clinical trial has been listed proposing the combination of Mirvaso and Dysport (the Galderma owned Botox-like product) to treat the redness and flushing of rosacea. So if you have ever wondered whether botox and Mirvaso might work well together, this trial is for you. The trial will examine how well the combination of Mirvaso […]
Described in the official trial only as a “topical cream”, Sol-Gel are undergoing a Phase 3 trial for a product newly designated as S5G4T-1. What is S5G4T-1? (Now Epsolay) Although the clinical trial listing doesn’t provide any details about the components of S5G4T-1, their own web site reveals more information. Based on Sol-Gel’s product portfolio, it seems […]
Allergan is sponsoring a clinical trial to evaluate whether their oxymetazoline HCL 1% based treatment – Rhofade, is an effective adjunctive treatment for rosacea patients undergoing treatments with Pulse Dye Laser (PDL), Intense Pulsed Light (IPL) or KTP Laser. The trial is designated as a Safety and Tolerability measure, so researchers will be looking for […]
